Proof of Concept in Neurodegeneration (Alzheimer’s & Parkinson’s)
Evaluate NRF2 contribution in translational neurodegenerative models. Alzheimer’s: APP/TAU ± NRF2 models; pathology, neuroinflammation, and behavior. Parkinson’s: MPTP and α-synuclein models; motor and nigrostriatal biomarkers. CNS-NRF2 panel: integration of oxidative stress and inflammasome markers.
*Contact us for details
Your Dynamic Snippet will be displayed here...
This message is displayed because youy did not provide both a filter and a template to use.